Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Eukaryotic Translation Initiation Factor 3, Subunit M (EIF3M) (AA 1-374) Antikörper

EIF3M Reaktivität: Human WB, IHC, ELISA, IP Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7152171
  • Target Alle Eukaryotic Translation Initiation Factor 3, Subunit M (EIF3M) Antikörper anzeigen
    Eukaryotic Translation Initiation Factor 3, Subunit M (EIF3M)
    Bindungsspezifität
    • 6
    • 3
    • 2
    • 1
    • 1
    • 1
    AA 1-374
    Reaktivität
    • 33
    • 23
    • 22
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 31
    • 1
    • 1
    Kaninchen
    Klonalität
    • 32
    • 1
    Polyklonal
    Konjugat
    • 15
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Unkonjugiert
    Applikation
    • 27
    • 13
    • 11
    • 10
    • 5
    • 4
    • 3
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunoprecipitation (IP)
    Kreuzreaktivität
    Human, Maus
    Aufreinigung
    Antigen Affinity Purified
    Immunogen
    Recombinant Human Eukaryotic translation initiation factor 3 subunit M protein (1-374AA)
    Isotyp
    IgG
    Top Product
    Discover our top product EIF3M Primärantikörper
  • Applikationshinweise
    Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200, IP:1:200-1:2000,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    Eukaryotic Translation Initiation Factor 3, Subunit M (EIF3M)
    Andere Bezeichnung
    EIF3M (EIF3M Produkte)
    Synonyme
    ga17 antikoerper, pcid1 antikoerper, hfl-b5 antikoerper, tango7 antikoerper, MGC69424 antikoerper, PCID1 antikoerper, DKFZp459D197 antikoerper, Ga17 antikoerper, Pcid1 antikoerper, Tango7 antikoerper, B5 antikoerper, TANGO7 antikoerper, hfl-B5 antikoerper, GA17 antikoerper, fa16c10 antikoerper, wu:fa16c10 antikoerper, wu:fc41f09 antikoerper, zgc:63996 antikoerper, HFL-B5 antikoerper, RGD1565840 antikoerper, eukaryotic translation initiation factor 3 subunit M antikoerper, eukaryotic translation initiation factor 3, subunit M antikoerper, eukaryotic translation initiation factor 3 subunit M S homeolog antikoerper, eif3m antikoerper, EIF3M antikoerper, Eif3m antikoerper, eif3m.S antikoerper
    Substanzklasse
    Viral Protein
    Hintergrund

    Background: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S preinitiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. May favor virus entry in case of infection with herpes simplex virus 1 (HSV1) or herpes simplex virus 2 (HSV2).

    Aliases: B5 antibody, B5 receptor antibody, Dendritic cell protein antibody, eIF3m antibody, EIF3M_HUMAN antibody, Eukaryotic translation initiation factor 3 subunit M antibody, Fetal lung protein B5 antibody, FLJ29030 antibody, GA17 antibody, hfl B5 antibody, hFL-B5 antibody, PCI domain containing 1 (herpesvirus entry mediator) antibody, PCI domain-containing protein 1 antibody, PCID1 antibody, TANGO7 antibody

    UniProt
    Q7L2H7
    Pathways
    Ribonucleoprotein Complex Subunit Organization
Sie sind hier: